Immunoconstructs from Macrophage Therapeutics

Immunoconstructs from Macrophage Therapeutics
Macrophage Therapeutics has developed recently the first two immunoconstructs namely MT-1001 and MT-2001 to target specifically activated CD206+ macrophages. By inhibiting the inflammatory activity of these macrophages with these immunoconstructs, numerous diseases like cancer, auto-immune diseases and central nervous system diseases like Alzheimer’s disease and multiple sclerosis could be cured.
How to cite this article:
Hameedunissa Begum Shariff. Immunoconstructs from Macrophage Therapeutics . BioLim O-Media. 16 March, 2017. 5(3).
Available from: http://archive.biolim.org/omedia/read/BOMA0198.